Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 19 2024
0mins
Source: Benzinga
- Wang & Lee Group Financial Results: Wang & Lee Group, Inc. reported a year-over-year increase in FY23 financial results with a loss of 2 cents per share compared to a loss of 5 cents per share the previous year and revenue of $6.83 million.
- Stock Movements: Several stocks saw significant movements in pre-market trading, including Redwoods Acquisition Corp., Zhongchao Inc., Trio Petroleum Corp., HUB Cyber Security Ltd., SuperCom Ltd., Bio-Path Holdings, Inc., Centogene N.V., Kineta, Inc., Paramount Global, and more.
- Netflix Stock Decline: Netflix, Inc. shares fell by 6% in pre-market trading despite reporting positive earnings and sales results for the first quarter and adding 9.33 million paid net new subscribers.
- BioNexus Gene Lab Investment: BioNexus Gene Lab Corp. fell 22.4% after agreeing to invest RM 1.2 million in Ascension Innovation (AISB) to advance digital health innovation through AI adoption in healthcare.
- Adaptive Biotechnologies Financial Report: Adaptive Biotechnologies Corporation shares declined by 11.4% as the company is expected to report financial results for the first quarter of 2024 after the closing bell on May 7, 2024.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZCMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZCMD
About ZCMD
Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zhongchao Inc. Announces Share Consolidation Plan
- Share Consolidation Details: Zhongchao Inc. will implement a 1-for-31 share consolidation on June 8, 2026, where every 31 Class A ordinary shares will convert into one share, aimed at maintaining its Nasdaq listing and enhancing market confidence.
- Capital Structure Changes: Prior to the consolidation, the company has 79,685,696 Class A and 624,972 Class B ordinary shares, with an expected post-consolidation total of approximately 2,570,507 Class A and 20,161 Class B shares, indicating efforts to optimize capital structure.
- Shareholder Impact: The consolidation will uniformly affect all shareholders, with adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's total shares, ensuring stability in shareholder equity.
- Management Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, reflecting transparency in corporate governance and compliance in decision-making.
See More
Zhongchao Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao has announced a 1-for-31 share consolidation of its ordinary shares, aiming to enhance the stock price per share by consolidating shares with a par value of $0.008 to meet Nasdaq Capital Market listing requirements.
- Trading Schedule: The consolidated ordinary shares will begin trading on Nasdaq under the same ticker symbol “ZCMD” starting June 8, ensuring that investors can smoothly transition to trading post-consolidation.
- Listing Maintenance Objective: The primary goal of this share consolidation is to maintain the company's listing on Nasdaq, reflecting its commitment to compliance and market recognition.
- Market Reaction Expectations: While the consolidation may have a positive short-term impact on the stock price, the company must continuously monitor market assessments of its long-term growth potential to ensure shareholder confidence and investor support.
See More
Zhongchao Inc. Prices Public Offering at $0.54 per Unit
- Offering Size: Zhongchao Inc. (ZCMD) has priced its best-efforts public offering at $0.54 per unit for a total of 9.26 million units, expecting gross proceeds of approximately $5 million, which highlights the company's ability to raise capital in the market.
- Subscription Details: Each unit consists of one Class A ordinary share and a warrant with an exercise price of $0.594 per share, expiring six months post-issuance, indicating the company's appeal to investors and potential returns.
- Market Performance: ZCMD's stock has traded between $0.08 and $12.18 over the past year, currently at $0.09, down 42.28% from Friday's close of $0.17, reflecting market caution regarding its future performance.
- Underwriter Role: Univest Securities, LLC serves as the sole placement agent for this offering, underscoring its significance and expertise in facilitating the company's capital-raising efforts.
See More
Biotech Stocks Show Significant Pre-Market Activity
- Significant Pre-Market Gains: Genenta Science S.p.A. (GNTA) surged 135% to $2.42 in pre-market trading, indicating strong market optimism about its potential breakthroughs, which may attract more investor interest.
- Healthy Choice Performance: Healthy Choice Wellness Corp. (HCWC) rose 30% to $0.43, reflecting increased market demand for its products, potentially boosting future sales and market share for the company.
- Pre-Market Decliners: Zhongchao Inc. (ZCMD) fell 34% to $0.11 in pre-market trading, signaling market concerns about its outlook, which may lead investors to reassess their investment strategies.
- Overall Market Sentiment: The overall pre-market activity in the biotech sector shows significant volatility, as investors seek potential breakout opportunities, which could influence trading strategies in the market.
See More
Zhongchao Inc. Prices $5 Million Public Offering
- Offering Size: Zhongchao Inc. announced a public offering priced at $0.54 per unit, with expected gross proceeds of approximately $5 million, demonstrating the company's ability to raise capital and confidence in future growth.
- Unit Composition: The offering consists of 9,259,260 units, each comprising one Class A ordinary share and one warrant, with an initial exercise price of $0.594 per share, enhancing potential returns for investors.
- Additional Purchase Option: Investors have the option to purchase additional units within 30 days post-closing, indicating strong market interest in Zhongchao's future growth and potentially increasing the company's liquidity.
- Underwriter Role: Univest Securities, LLC acts as the sole placement agent for the offering, facilitating the transaction's smooth execution and reflecting its expertise and trust in Zhongchao's prospects.
See More
Zhongchao Inc. Prices $5 Million Public Offering
- Offering Size: Zhongchao Inc. has announced a public offering priced at $0.54 per unit, with expected gross proceeds of approximately $5 million, reflecting the company's ability to raise capital and confidence in future growth.
- Unit Composition: The offering consists of 9,259,260 units, each comprising one Class A ordinary share and a warrant, with an initial exercise price of $0.594 per share, enhancing potential returns for investors.
- Additional Purchase Option: Investors have the option to purchase additional units within 30 days post-offering, indicating strong market interest in Zhongchao's future growth and potentially increasing the company's liquidity.
- Underwriter Role: Univest Securities, LLC acts as the sole placement agent for the offering, showcasing its expertise and influence in facilitating this financing for the company.
See More
Zhongchao Inc. Announces Share Consolidation Plan
- Share Consolidation Details: Zhongchao Inc. will implement a 1-for-31 share consolidation on June 8, 2026, where every 31 Class A ordinary shares will convert into one share, aimed at maintaining its Nasdaq listing and enhancing market confidence.
- Capital Structure Changes: Prior to the consolidation, the company has 79,685,696 Class A and 624,972 Class B ordinary shares, with an expected post-consolidation total of approximately 2,570,507 Class A and 20,161 Class B shares, indicating efforts to optimize capital structure.
- Shareholder Impact: The consolidation will uniformly affect all shareholders, with adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's total shares, ensuring stability in shareholder equity.
- Management Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, reflecting transparency in corporate governance and compliance in decision-making.
See More
Zhongchao Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao has announced a 1-for-31 share consolidation of its ordinary shares, aiming to enhance the stock price per share by consolidating shares with a par value of $0.008 to meet Nasdaq Capital Market listing requirements.
- Trading Schedule: The consolidated ordinary shares will begin trading on Nasdaq under the same ticker symbol “ZCMD” starting June 8, ensuring that investors can smoothly transition to trading post-consolidation.
- Listing Maintenance Objective: The primary goal of this share consolidation is to maintain the company's listing on Nasdaq, reflecting its commitment to compliance and market recognition.
- Market Reaction Expectations: While the consolidation may have a positive short-term impact on the stock price, the company must continuously monitor market assessments of its long-term growth potential to ensure shareholder confidence and investor support.
See More
Zhongchao Inc. Prices Public Offering at $0.54 per Unit
- Offering Size: Zhongchao Inc. (ZCMD) has priced its best-efforts public offering at $0.54 per unit for a total of 9.26 million units, expecting gross proceeds of approximately $5 million, which highlights the company's ability to raise capital in the market.
- Subscription Details: Each unit consists of one Class A ordinary share and a warrant with an exercise price of $0.594 per share, expiring six months post-issuance, indicating the company's appeal to investors and potential returns.
- Market Performance: ZCMD's stock has traded between $0.08 and $12.18 over the past year, currently at $0.09, down 42.28% from Friday's close of $0.17, reflecting market caution regarding its future performance.
- Underwriter Role: Univest Securities, LLC serves as the sole placement agent for this offering, underscoring its significance and expertise in facilitating the company's capital-raising efforts.
See More
Biotech Stocks Show Significant Pre-Market Activity
- Significant Pre-Market Gains: Genenta Science S.p.A. (GNTA) surged 135% to $2.42 in pre-market trading, indicating strong market optimism about its potential breakthroughs, which may attract more investor interest.
- Healthy Choice Performance: Healthy Choice Wellness Corp. (HCWC) rose 30% to $0.43, reflecting increased market demand for its products, potentially boosting future sales and market share for the company.
- Pre-Market Decliners: Zhongchao Inc. (ZCMD) fell 34% to $0.11 in pre-market trading, signaling market concerns about its outlook, which may lead investors to reassess their investment strategies.
- Overall Market Sentiment: The overall pre-market activity in the biotech sector shows significant volatility, as investors seek potential breakout opportunities, which could influence trading strategies in the market.
See More
Zhongchao Inc. Prices $5 Million Public Offering
- Offering Size: Zhongchao Inc. announced a public offering priced at $0.54 per unit, with expected gross proceeds of approximately $5 million, demonstrating the company's ability to raise capital and confidence in future growth.
- Unit Composition: The offering consists of 9,259,260 units, each comprising one Class A ordinary share and one warrant, with an initial exercise price of $0.594 per share, enhancing potential returns for investors.
- Additional Purchase Option: Investors have the option to purchase additional units within 30 days post-closing, indicating strong market interest in Zhongchao's future growth and potentially increasing the company's liquidity.
- Underwriter Role: Univest Securities, LLC acts as the sole placement agent for the offering, facilitating the transaction's smooth execution and reflecting its expertise and trust in Zhongchao's prospects.
See More
Zhongchao Inc. Prices $5 Million Public Offering
- Offering Size: Zhongchao Inc. has announced a public offering priced at $0.54 per unit, with expected gross proceeds of approximately $5 million, reflecting the company's ability to raise capital and confidence in future growth.
- Unit Composition: The offering consists of 9,259,260 units, each comprising one Class A ordinary share and a warrant, with an initial exercise price of $0.594 per share, enhancing potential returns for investors.
- Additional Purchase Option: Investors have the option to purchase additional units within 30 days post-offering, indicating strong market interest in Zhongchao's future growth and potentially increasing the company's liquidity.
- Underwriter Role: Univest Securities, LLC acts as the sole placement agent for the offering, showcasing its expertise and influence in facilitating this financing for the company.
See More
